Temi Oduozor
Nessuna posizione attualmente
Profilo
Temi Oduozor worked as a Controller at Anthera Pharmaceuticals, Inc. from 2011 to 2014, at Questcor Pharmaceuticals, Inc. from 2008 to 2011, and as the Controller, Chief Financial & Accounting Officer at Giga-tronics, Inc. from 2016 to 2018.
Oduozor obtained an undergraduate degree from The California State University.
Precedenti posizioni note di Temi Oduozor
Società | Posizione | Fine |
---|---|---|
GRESHAM WORLDWIDE, INC. | Direttore Finanziario/CFO | 23/02/2018 |
ANTHERA PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 01/11/2014 |
QUESTCOR PHARMACEUTICALS INC | Comptroller/Controller/Auditor | 01/01/2011 |
Formazione di Temi Oduozor
The California State University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
GRESHAM WORLDWIDE, INC. | Electronic Technology |
ANTHERA PHARMACEUTICALS, INC. | Health Technology |
Aziende private | 1 |
---|---|
Questcor Pharmaceuticals, Inc.
Questcor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Questcor Pharmaceuticals, Inc. was engaged in development, marketing and sale of prescription drugs. It operated as a biopharmaceutical company which focuses on the treatment of patients with serious, difficult-to-treat autoimmune and inflammatory disorders. The company's primary product was H.P. Acthar Gel, an injectable drug for the treatment of proteinuria in the nephrotic syndrome of the idiopathic type, or NS, the treatment of acute exacerbations of multiple sclerosis, or MS, in adults, the treatment of infantile spasms, or IS, in infants and children under two years of age, and the treatment of certain rheumatology related conditions, including the treatment of the rare and closely related neuromuscular disorders dermatomyositis and polymyositis. Questcor Pharmaceuticals was founded in September 1992 and was headquartered in Anaheim, CA. | Health Technology |
- Borsa valori
- Insiders
- Temi Oduozor